IBRX

NASDAQStock

ImmunityBio, Inc.

$8.00-0.28 (-3.33%)

52-Week Range

$1.89

$10.44

Key Stats

Market Cap

8.2B

P/E Ratio

N/A

Dividend Yield

N/A

Beta

-0.08

Volume

12.3M

Avg Volume

36.3M

Performance

+19.57%

+252.25%

+185.40%

YTD

+287.13%

+169.66%

+450.70%

-74.63%

Price Chart

ETF Exposure

IBRX is held by 72 ETFs

ETF	Fund Name	Weight	Shares	Market Value	Fund AUM	Expense Ratio
SPGM	State Street SPDR Portfolio MSCI Global Stock Market ETF	0.01%	9,427	$73K	$1.43B	0.09%
ITOT	iShares Core S&P Total U.S. Stock Market ETF	0.00%	448,382	$3.6M	$81.53B	0.03%
IWV	iShares Russell 3000 ETF	0.00%	78,776	$631K	$17.58B	0.20%
SCHB	Schwab U.S. Broad Market ETF	0.00%	169,895	$1.4M	$38.14B	0.03%
VTHR	Vanguard Russell 3000 ETF	0.00%	24,506	$153K	$5.50B	0.06%
VTI	Vanguard Total Stock Market ETF	0.00%	11,634,136	$72.7M	$2.10T	0.03%
AVLC	Avantis U.S. Large Cap Equity ETF	0.00%	788	$6K	$1.03B	0.15%
ITDD	iShares LifePath Target Date 2040 ETF	0.00%	140	$1K	$81.7M	0.11%
ITDE	iShares LifePath Target Date 2045 ETF	0.00%	161	$1K	$64.1M	0.11%
ITDF	iShares LifePath Target Date 2050 ETF	0.00%	190	$2K	$59.0M	0.11%
ITDG	iShares LifePath Target Date 2055 ETF	0.00%	158	$1K	$42.9M	0.12%
ITDH	iShares LifePath Target Date 2060 ETF	0.00%	105	$838	$28.3M	0.12%
ITDI	iShares LifePath Target Date 2065 ETF	0.00%	79	$633	$21.4M	0.12%
ITDJ	iShares LifePath Target Date 2070 ETF	0.00%	35	$281	$9.5M	0.12%
ITDB	iShares LifePath Target Date 2030 ETF	0.00%	25	$199	$61.4M	0.09%
ITDC	iShares LifePath Target Date 2035 ETF	0.00%	82	$657	$81.5M	0.10%
LSLT	Pacer Salt Low truBeta US Market ETF	0.00%	7,897	$44K	$6.8M	0.60%
SLT	Pacer Salt High truBeta US Market ETF	0.00%	7,897	$44K	$6.3M	0.60%
TILT	FlexShares Morningstar U.S. Market Factor Tilt Index Fund	0.00%	612	$5K	$1.90B	0.26%
TRPL	Pacer Metaurus US Large Cap Dividend Multiplier 300 ETF	0.00%	7,897	$44K	$1.0M	0.79%
VETS	Pacer Military Times Best Employers ETF	0.00%	7,897	$44K	$1.9M	0.60%
VIRS	Pacer BioThreat Strategy ETF	0.00%	7,897	$44K	$3.7M	0.70%

PreviousPage 2 of 2

About IBRX ETF Exposure

ImmunityBio, Inc. (IBRX) is held by 72 exchange-traded funds, making it one of the stocks with significant ETF exposure. With a market capitalization of 8.2B, IBRX is a widely held institutional stock. The stock currently trades at $8.00. Investors can gain exposure to IBRX through a variety of ETFs with different expense ratios, investment strategies, and portfolio weightings. The table above shows all ETFs that currently hold IBRX, sorted by portfolio weight.